Only CD4 + T-cell counts < 100 cells/mm3 reached statistical significance in multivariate analysis as a predictor of this website the risk of cryptosporidiosis. It is clear that CD4 + T-lymphocytes are necessary for resolution of cryptosporidiosis. The risk of Cryptosporidiosis in
immunosuppressed patients correlates with CD4 + T-lymphocytes counts (23, 24). In the present study, the majority of infections occurred in HIV positive individuals (63.3%), of whom 57% had CD4 + T-lymphocytes counts < 100 cells/mm3. The evidence indicates that Cryptosporidium does not pose a particular risk to cancer patients in general. The exception to this rule seems to be leukemia and other hematological malignancies (25, 26). The severe disease seen in bone marrow transplant patients usually appears to depend on and reflect the underlying diagnosis for which the transplant was performed (4). The introduction and use of HAART for immune reconstitution has dramatically
learn more reduced the incidence of cryptosporidiosis in HIV/AIDS patients. However, HAART is still not widely available in many non-industrialized countries, where cryptosporidiosis remains an important emerging disease (2). In conclusion, the results of this study indicate that the presence of Cryptosporidium may be high among HIV infected patients, patients with hematological malignancies (especially ALL and CLL) and in bone marrow transplant patients, many living in Isfahan province, central Iran; however, evaluation of immunocompromised patients in other areas is required.
In addition, cryptosporidiosis is more likely to be present in patients with particular signs and symptoms, such as diarrhea, weight loss, and dehydration. Moreover, we recommend that patients with CD4 + T-lymphocyte counts < 100 cells/mm3 be assessed for cryptosporidiosis. Our overall recommendation is to consider cryptosporidiosis as a cause of diarrhea in HIV infected patients and patients with CD4 + T-lymphocyte counts < 100cells/mm3. Additional precautions, including avoiding contact with diarrheal individuals among their household members, may help to prevent fecal-oral transmission. We would like to acknowledge all who collaborated in this study, especially the patients who provided specimens. The authors declare that they have no conflicts of interest related to this study. "
“To determine the interplay between fetal antigenicity and local maternal factors in determining reproductive tract T regulatory (Treg) cell accumulation during pregnancy. Examination of maternal Treg composition in the uterus, cervix, and uteroplacental interface (UPI) of murine syngeneic and allogeneic pregnancies and non-pregnant controls by flow cytometry. The impact of fetal antigenicity was defined by either fetal gender in syngeneic pregnancies or by allogeneic paternity.